Management Team

Namrata Saroj, OD

Chief Business Officer

Namrata Saroj, OD brings over 20 years of experience focusing on global development and commercialization of drugs and technologies advancing ophthalmic care. Her extensive understanding of the ophthalmology clinical and commercial landscapes is founded on her diverse experiences working across multiple programs. She has collaborated with multiple companies across various stages from early start-ups to late-stage development and commercialization. In this capacity, she has effectively helped these companies with strategic partnerships, clinical development, trial enrollment, launch preparation and commercialization support.

Dr. Saroj has been a significant contributor towards the commercialization of LUCENTIS^® and EYLEA^®, two of the most successful products in this sector. She is established in the retina community for her work in clinical development collaborating with investigators and industry experts on clinical trial designs and execution. She has co-authored several peer-reviewed publications in the management of retinal diseases.

Dr. Saroj is also the co-founder of Clinical Trials Resource Group, a CRO focused on executing ophthalmology clinical trials. Previously, she led the Ophthalmology Medical Affairs team as an Executive Director at Regeneron Pharmaceuticals, Inc. Dr. Saroj has previously held positions at Genentech, Inc. and Manhattan Eye, Ear & Throat Hospital. Dr. Saroj is the President of Association for Macular Diseases, a non-profit organization offering support to individuals, their families, friends, and the professional community.

Dr. Saroj earned her Doctor of Optometry from the University of California, Berkeley. She received a Bachelor of Science in Optometry from the University of California, Berkeley and Bachelor of Arts in Biochemistry, magna cum laude with distinction from Whittier College.